The situation is further complicated by contradictory reports regarding the role of phosphorylated versus an unphosphorylated form of MARCKS as an oncogene versus tumor suppressor in blood cancers. This evidence concerns the gene MARCKS and hematopoietic and lymphoid system neoplasm.